Fingerprint
Dive into the research topics of 'Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease
Sebastiaan Ten Bokkel Huinink, Vince Biemans, Marjolijn Duijvestein, Marieke Pierik, Frank Hoentjen, Rachel L West, Christien J van der Woude, Annemarie C de Vries*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review